Nancy Lynn Snyderman M.D., Director at Lyra Therapeutics, Inc. (LYRA), bought 1,025 shares at $9.72 ($10K) on 2020-12-16, disclosed to the SEC on 2020-12-17.
Open-market purchase of $10k LYRA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| AXNX | BUY | 2019-07-01 | $74K | — | Filing → |